Literature DB >> 16413038

Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant gamma-tocotrienol.

K Sree Kumar1, Mythili Raghavan, Kevin Hieber, Christine Ege, Steven Mog, Nannette Parra, Annette Hildabrand, Vijay Singh, V Srinivasan, Raymond Toles, Patience Karikari, Gyorgy Petrovics, Thomas Seed, Shiv Srivastava, Andreas Papas.   

Abstract

Gamma-tocotrienol (GT) is a member of the vitamin E family. Our preliminary studies indicated that it protected mice from lethal irradiation, so we hypothesized that GT might be a radiation sensitizing agent for tumors. To test this, we induced prostate tumors by injecting PC3 cells into nude BALB/c mice. When the tumors were about 5 mm in diameter, mice were injected subcutaneously with 400 mg/kg gamma-tocotrienol and irradiated 24 h later at the site of the tumor with a dose of 12 Gy (60)Cobalt. Tumor size was monitored for 24 days after radiation. Tumor tissues as well as normal tissues like rectum, kidney, and liver were monitored for lipid peroxidation on day 4 and day 24 after radiation. The results indicated that the size of the tumors was reduced by almost 40%, but only in GT-treated and irradiated mice. In unstimulated and Fe-stimulated lipid peroxidation groups, lipid peroxidation in the tumors from irradiated mice increased to 135% and 150%, respectively, four days after irradiation and 33% and 66% in the same groups, respectively, 24 days after irradiation. In general, lipid peroxidation in the rectum did not increase in GT-treated and irradiated mice, although there was a slight increase in Fe-stimulated lipid peroxidation (29%) four days after irradiation. Unexpectedly, the kidneys were as equally sensitized to lipid peroxidation as the tumors. Liver tissue was protected in the short-term from radiation-induced lipid peroxidation. These studies indicate that the radiotherapy efficacy of prostate cancer can be increased with GT and a pro-oxidant if the kidneys can be shielded.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413038     DOI: 10.1016/j.lfs.2005.12.005

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  21 in total

1.  {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.

Authors:  Ajaikumar B Kunnumakkara; Bokyung Sung; Jayaraj Ravindran; Parmeswaran Diagaradjane; Amit Deorukhkar; Sanjit Dey; Cemile Koca; Vivek R Yadav; Zhimin Tong; Juri G Gelovani; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2010-09-23       Impact factor: 12.701

2.  Tocotrienol vitamin E protects against preclinical canine ischemic stroke by inducing arteriogenesis.

Authors:  Cameron Rink; Greg Christoforidis; Savita Khanna; Laura Peterson; Yojan Patel; Suchin Khanna; Amir Abduljalil; Okan Irfanoglu; Raghu Machiraju; Valerie K Bergdall; Chandan K Sen
Journal:  J Cereb Blood Flow Metab       Date:  2011-06-15       Impact factor: 6.200

Review 3.  Natural Forms of Vitamin E as Effective Agents for Cancer Prevention and Therapy.

Authors:  Qing Jiang
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

4.  γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent.

Authors:  Peramaiyan Rajendran; Feng Li; Kanjoormana Aryan Manu; Muthu K Shanmugam; Ser Yue Loo; Alan Prem Kumar; Gautam Sethi
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

5.  γ-Tocotrienol protects against mitochondrial dysfunction and renal cell death.

Authors:  Grazyna Nowak; Diana Bakajsova; Corey Hayes; Martin Hauer-Jensen; Cesar M Compadre
Journal:  J Pharmacol Exp Ther       Date:  2011-10-31       Impact factor: 4.030

6.  Why tocotrienols work better: insights into the in vitro anti-cancer mechanism of vitamin E.

Authors:  Valentina Viola; Francesca Pilolli; Marta Piroddi; Elisa Pierpaoli; Fiorenza Orlando; Mauro Provinciali; Michele Betti; Francesco Mazzini; Francesco Galli
Journal:  Genes Nutr       Date:  2011-04-20       Impact factor: 5.523

Review 7.  Novel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory?

Authors:  Maaike Berbée; Martin Hauer-Jensen
Journal:  Curr Opin Support Palliat Care       Date:  2012-03       Impact factor: 2.302

8.  Is vitamin E toxic to neuron cells?

Authors:  Sue Mian Then; Musalmah Mazlan; Gapor Mat Top; Wan Zurinah Wan Ngah
Journal:  Cell Mol Neurobiol       Date:  2009-01-27       Impact factor: 5.046

9.  Vitamin E delta-tocotrienol levels in tumor and pancreatic tissue of mice after oral administration.

Authors:  Kazim Husain; Rony A Francois; Sean Z Hutchinson; Anthony M Neuger; Richard Lush; Domenico Coppola; Said Sebti; Mokenge P Malafa
Journal:  Pharmacology       Date:  2009-01-13       Impact factor: 2.547

Review 10.  Tocotrienols: the emerging face of natural vitamin E.

Authors:  Chandan K Sen; Savita Khanna; Cameron Rink; Sashwati Roy
Journal:  Vitam Horm       Date:  2007       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.